News

Cupron® Performance Additives Unveils Groundbreaking “Clear” Liquid Copper Platform for Sustainable Microbial Control Applications

Cupron Performance Additives (Cupron) today announced the launch of Cupron Clear™ — a revolutionary new liquid microbial copper platform. Cupron Clear™ is a transparent, stable, and highly efficacious liquid form of copper, designed for broad use across polymers and liquids. This new breakthrough delivers unmatched microbial control while exceeding modern standards for sustainability, economics, and safety.

Cupron Clear™ reinvents the chemistry of copper-based additives for liquid products, delivering over a hundred times the effectiveness of conventional copper solutions. With its innovative clear liquid format, Cupron Clear™ out-performs incumbent additives such as QUATs and Isothiazolinones, many of which are facing growing regulatory pressure. Cupron Clear™ sets a new standard for broad-spectrum efficacy against microorganisms. This next-generation technology provides end market and downstream users with a more sustainable, versatile, and high-performing copper-based biocide than ever before.

“This new liquid copper platform addresses the frustrations for so many different industries and dramatically expands the applications that can enjoy the benefits of Cupron innovations,” said Chris Andrews, CEO of Cupron. “It’s the direct result of focused R&D and our belief that economic, safer, sustainable technologies should replace legacy materials that no longer meet regulatory or performance standards.”

Representing a major leap forward in copper-based technologies, Cupron Clear™ is a first-to-market solution for personal care, hygiene, building & construction, textiles, plastics, paints and other coatings, adhesives, sealants, elastomers (C.A.S.E.) markets in need of the highest-performing form of cuprous copper in a colorless, liquid format.

“With the addition of Cupron Clear™ to the company’s product portfolio, we can now offer our partners unparalleled flexibility in manufacturing and application with a comprehensive suite of platforms across solid, dispersion and solution-based applications,” Andrews added.

In addition to securing patents and intellectual property rights across composition, process, and applications of Cupron Clear™, Cupron is already in discussion with global partners and distributors to deploy it across core markets.

Read more here.

Recent News

08/26/2025

Activation Capital Names Michael Steele as President and CEO

The Virginia Biotechnology Research Partnership Authority (doing business as Activation Capital) announced today that it has appointed Michael Steele as president and chief executive officer. Steele succeeds Robert Ward, who has served as interim CEO since July 2024 during a period of rapid growth for the life sciences ecosystem development organization. Steele comes to Activation

08/25/2025

Danforth Advisors Acquires PharmaDirections

Danforth Advisors LLC, today announced the acquisition of PharmaDirections, Inc., a full-spectrum development partner to life science companies, expanding its integrated capabilities from discovery through commercialization. Founded in 2003, PharmaDirections was a pioneer of the virtual drug development model. The company brings veteran program leaders and more than 150 specialists to support strategic planning and

08/22/2025

ivWatch Technology Linked to Major Reduction in Severe IV Injuries in Newborns Over Four-Year Study

A study published this month in The BMJ (British Medical Journal) analyzed the use of optical sensor technology from ivWatch, the U.S.-based IV safety company, in the early detection of peripheral intravenous infiltration or extravasation (PIVIE) events in neonates. Presenting a comparative evaluation between conventional observational methods and continuous sensor-based monitoring, the study offers insights